Organization of Investor Relations Event
1. Date & Time Opening Date Time
From To From To
2022-03-04 2022-03-04 14:00 17:00
2. Place Seoul
3. Participant Sell-side analysts in the pharmaceutical/biotech sector
4. Purpose
Introducing RNAi drug development progress a
nd pipeline
5. Method
Analyst's Day Event
6. Major Contents
○ BIO EUROPE SPRING 2022 Preview

1. Progress update on a new drug candidate for fibrosis

2. Progress update on hair-loss(androgenic alopecia) related new drug candidate, in European cosmeceuticals and US OTC drugs market

3. Introduction to previously undisclosed pipelines, including research results that have penetrated the blood-brain barrier (BBB)

4. J.P. Morgan Healthcare Conference follow-up meeting progress

5. Q&A
7. Sponsor self-organized
8. Opening Decision Date 2022-02-25
9. Person in charge of IR Department(Name) IR Division(D.H Linus Hwang, Head of IR)
Contact Number(Fax Number) 02-739-6083 (02-6303-0046)
10. IR Material Publication Publication Date 2022-03-04
Publication Place - KRX Kind System (http://kind.krx.co.kr)
- IR page on our website

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Bioneer Corporation published this content on 25 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 February 2022 07:21:05 UTC.